Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Venrock Adviser, LLC
Form 13F · Q2 2026

Venrock Adviser, LLC

CIK 1615982申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$33.0亿
申报组合市值
33
持仓数量
12
Quarters on record
Top 50
持仓数量

Venrock Adviser, LLC——持仓

共 33 个持仓中的前 33 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1APOGEE THERAPEUTICS INC Apogee Therapeutics Inc8.5M+0.0%$11.3亿34.2%
2ORKA Oruka Therapeutics Inc4.1M+0.0%$3.9亿12.0%
3ERAS Erasca Inc17.9M+9.2%$3.3亿9.9%
4SYRE Spyre Therapeutics Inc3.0M−19.0%$2.7亿8.0%
5DNTH Dianthus Therapeutics Inc1.2M+0.0%$1.2亿3.5%
6OCUL Ocular Therapeutix Inc10.3M+0.0%$1.0亿3.1%
7DMRA Damora Therapeutics Inc3.6M+0.0%$9373万2.8%
8SVRA Savara Inc14.7M+7.3%$9084万2.8%
9JBIO Jade Biosciences Inc3.2M+0.0%$7156万2.2%
10COGT Cogent Biosciences Inc1.6M−17.9%$6355万1.9%
11VRDN Viridian Therapeutics Inc3.3M−16.1%$5985万1.8%
12VOR Vor Biopharma Inc3.0M+0.0%$5600万1.7%
13DYN Dyne Therapeutics Inc2.2M+0.0%$4828万1.5%
14MAZE Maze Therapeutics Inc1.6M+0.0%$4780万1.4%
15RLMD Relmada Therapeutics Inc6.8M+41.3%$4736万1.4%
16ORIC Oric Pharmaceuticals Inc4.3M+0.0%$4678万1.4%
17CBIO Crescent Biopharma Inc.2.1M+0.0%$3840万1.2%
18ZURA Zura Bio Ltd6.4M+0.0%$3797万1.2%
19ANL Adlai Nortye Ltd3.2M+0.0%$3695万1.1%
20ELVN Enliven Therapeutics Inc526,331−69.5%$2671万0.8%
21HELP Cybin Inc3.9M+0.0%$2546万0.8%
22CGEM Cullinan Therapeutics Inc1.4M+0.0%$2513万0.8%
23IPSC Century Therapeutics Inc8.7M+0.0%$2130万0.6%
24ARTV Artiva Biotherapeutics Inc2.0M+27.0%$1982万0.6%
25CTMX Cytomx Therapeutics Inc.5.0M−50.1%$1868万0.6%
26QUIT Achieve Life Science Inc2.8M—$1796万0.5%
27PBLS Parabilis Medicines Inc625,000—$1711万0.5%
28SRZN Surrozen Inc632,931+0.0%$1642万0.5%
29KRRO Korro Bio Inc1.0M+0.0%$1331万0.4%
30ANRO Alto Neuroscience Inc500,000+0.0%$1320万0.4%
31XFOR X4 Pharmaceuticals Inc1.9M+485.2%$903万0.3%
32RACC Research Alliance Corp Iii300,000—$321万0.1%
33MTRI Inmed Pharmaceuticals Inc32,685—$5万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。